Management of Symptomatic Uterine Fibroids in Pregnancy by Laparotomic Myomectomy: a Prospective Cohort Study
NCT ID: NCT06009562
Last Updated: 2023-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
28 participants
OBSERVATIONAL
2023-08-19
2024-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pregnancy Outcomes Following Myomectomy
NCT06474065
Resectoscopic Treatment of Atypical Endometrial Polyps in Fertile Women
NCT00490087
Does Preventive Uterine Artery Occlusion During Laparoscopic Myomectomy Impact on Ovarian Reserve Markers?
NCT02563392
Questionnaire Study to Assess Quality of Life After Treatment of Fibroids
NCT00390494
Sonographic Features of Fibroids Before and During Non-surgical Therapy and/or Expectant Management
NCT05741671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparotomic myomectomy during pregnancy
Surgical removal of symptomatic uterine fibroids in pregnancy by laparotomic access
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Circulatory disorders, evidenced by necrosis of the UFs.
* Atypical localization of UFs (cervical, isthmic, intraligamentary, etc.), which caused pelvic organ dysfunction (dysuric phenomena, tenesmus, impediment to the act of defecation, pelvic pain).
Exclusion Criteria
* Absence of urgent indication for LPTM during pregnancy.
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Palermo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Etrusco
M.D.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrea Etrusco, M.D.
Role: PRINCIPAL_INVESTIGATOR
University of Palermo
Antonio Simone Laganà , M.D. Ph.D.
Role: STUDY_DIRECTOR
University of Palermo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
State-Funded Health Care Facility of Moscow Region (GBUZ MO MONIIAG)
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LPTM-S-UFs-Pregancy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.